Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer
Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
This single-center, open-label, phaseâ… study is to evaluate the efficacy of Tislelizumab in
combination with Bevacizumab and Pemetrexed for the first-line treatment of advanced
Non-squamous Non-small Cell lung cancer in Elderly Patients
Phase:
Phase 1
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital